Want to see ACRV full AI Analyst Report?
Acrivon Therapeutics, Inc. (ACRV) Income Statement
Acrivon Therapeutics, Inc. Income Statement
Last quarter (Q2 2026), Acrivon Therapeutics, Inc.'s total revenue was $0.00. In Q2, Acrivon Therapeutics, Inc.'s net income was $-17.96M. See Acrivon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.36M | $ -1.01M | $ -536.00K | $ 0.00 | $ 0.00 | |
| $ 82.76M | $ 88.19M | $ 66.70M | $ 32.66M | $ 16.18M | |
| Depreciation and Amortization | $ 1.36M | $ 1.01M | $ 536.00K | $ 364.00K | $ 37.00K |
| $ -76.55M | $ -79.55M | $ -59.85M | $ -30.80M | $ -16.21M | |
| $ -84.11M | $ -89.20M | $ -67.24M | $ -32.66M | $ -16.18M | |
| $ 6.21M | $ 8.64M | $ 6.85M | $ 1.49M | $ -59.00K | |
| $ -77.91M | $ -80.56M | $ -60.39M | $ -31.17M | $ -16.24M | |
| $ -77.91M | $ -80.56M | $ -60.39M | $ -31.17M | $ -16.24M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.02 | $ -2.10 | $ -2.74 | $ -1.42 | $ -1.26 |
| Diluted EPS | $ -2.02 | $ -2.10 | $ -2.74 | $ -1.42 | $ -1.26 |
| Weighted Average Shares Outstanding | 38.51M | 38.30M | 22.08M | 21.92M | 12.91M |
| Weighted Average Shares Outstanding (Diluted) | 38.51M | 38.30M | 22.08M | 21.92M | 12.91M |
Currency in USD